Patents-Review.com
ClassID:

20405 ⎘

A61K31/485 - page 3 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Quinolines; Isoquinolines Morphinan derivatives, e.g. morphine, codeine

Recent Application in this class:
#601
20220143010
2022-05-12

CANCER TREATMENT COMPRISING NALTREXONE AND A CANNABINOID

 #602
20220142950
2022-05-12

Bupropion as modulator of drug activity

 #603
20220135564
2022-05-05

DEUTERATED MITRAGYNINE ANALOGS AS SAFER OPIOID MODULATORS IN THE MITRAGYNINE CLASS

 #604
20220133655
2022-05-05

Bupropion as a modulator of drug activity

 #605
20220126030
2022-04-28

DEVICES FOR EVAPORATION AND INHALATION OF ACTIVE AGENTS

 #606
20220125781
2022-04-28

Methods and Compositions for Treating Vasomotor Symptoms

 #607
20220125739
2022-04-28

Abuse and misuse deterrent transdermal systems

 #608
20220118026
2022-04-21

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

 #609
20220117913
2022-04-21

DEZOCINE DERIVATIVE AND MEDICAL USE THEREOF

 #610
20220110982
2022-04-14

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

 #611
20220110932
2022-04-14

Methods and compositions for maintaining opioid efficacy in the treatment of pain

 #612
20220110879
2022-04-14

Immediate release abuse-deterrent granulated dosage forms

 #613
20220110315
2022-04-14

SOLUTIONS AND METHODS FOR ORGAN PRESERVATION

 #614
20220105088
2022-04-07

PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF DEPRESSON, ANXIETY, AND NEURODEGENERATIVE DISORDERS

 #615
20220105087
2022-04-07

Increasing Drug Bioavailability In Naltrexone Therapy

 #616
20220105086
2022-04-07

Bupropion as a modulator of drug activity

 #617
20220105085
2022-04-07

ABRASION-RESISTANT OPIOID FORMULATIONS WHICH RESIST ABUSE AND INCLUDE A SEQUESTERED OPIOID ANTAGONIST

 #618
20220105084
2022-04-07

PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF AGITATION IN DEMENTIA

 #619
20220096463
2022-03-31

Levorphanol prodrugs and processes for making and using them

 #620
20220096462
2022-03-31

Bupropion as a modulator of drug activity

 #621
20220096461
2022-03-31

LIQUID ORAL DOSAGE FORMULATIONS OF METHYLNALTREXONE

 #622
20220096460
2022-03-31

ABUSE-RESISTANT LONG-ACTING RELEASE OPIOID PRODRUGS

 #623
20220096430
2022-03-31

Devices and methods for facilitating and controlling use of a medication

 #624
20220088007
2022-03-24

Increasing Drug Bioavailability In Naltrexone Therapy

 #625
20220079938
2022-03-17

PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF ALPHA, BETA-UNSATURATED KETONE COMPOUNDS

 #626
20220079937
2022-03-17

PHARMACEUTICAL FORMULATION

 #627
20220079892
2022-03-17

Bupropion as a modulator of drug activity

 #628
20220073583
2022-03-10

Acylated glucagon analogues

 #629
20220071991
2022-03-10

EXTENDED RELEASE COMPOSITIONS OF OPIOID ANTAGONISTS AND PHOSPHODIESTERASE 5 INHIBITORS

 #630
20220071990
2022-03-10

Immediate release abuse-deterrent granulated dosage forms

 #631
20220071989
2022-03-10

METHODS OF TREATING NEGATIVE SYMPTOMS OF SCHIZOPHRENIA USING DEUTERATED DEXTROMETHORPHAN AND QUINIDINE

 #632
20220071988
2022-03-10

SUSTAINED RELEASE BUPRENORPHINE MICROSPHERES (SRBM) AND METHODS OF USE THEREOF

 #633
20220071987
2022-03-10

PHARMACEUTICAL FORMULATIONS FOR SUSTAINED RELEASE OF SEBACOYL DINALBUPHINE ESTER

 #634
20220071931
2022-03-10

Bupropion as a modulator of drug activity

 #635
20220071930
2022-03-10

Bupropion as a modulator of drug activity

 #636
20220071896
2022-03-10

NASAL DRUG PRODUCTS AND METHODS OF THEIR USE

 #637
20220062602
2022-03-03

Devices and methods for delivery of pharmaceutical compositions

 #638
20220062277
2022-03-03

Naltrexone injectable sustained release formulation

 #639
20220062276
2022-03-03

PHARMACEUTICAL COMPOSITIONS

 #640
20220062275
2022-03-03

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

 #641
20220062194
2022-03-03

Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors

 #642
20220054479
2022-02-24

OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE

 #643
20220048910
2022-02-17

ORGANIC COMPOUNDS

 #644
20220047590
2022-02-17

Wound treatments and compositions

 #645
20220047580
2022-02-17

METHOD FOR TREATING DRUG OR ALCOHOL DEPENDENCY

 #646
20220047579
2022-02-17

INJECTABLE SUSTAINED RELEASE BUPRENORPHINE FORMULATION

 #647
20220047566
2022-02-17

LONG ACTING IN-SITU FORMING/GELLING COMPOSITIONS

 #648
20220041612
2022-02-10

Opioid ketal compounds and uses thereof

 #649
20220040295
2022-02-10

Treatment of Cancer With Naltrexone

 #650
20220034865
2022-02-03

Diagnostic methods, therapeutic agents and uses thereof

 #651
20220031693
2022-02-03

Tamper resistant immediate release formulations

 #652
20220031692
2022-02-03

Buprenorphine dosing regimens

 #653
20220031691
2022-02-03

Bupropion as a modulator of drug activity

 #654
20220023292
2022-01-27

COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLOGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY

 #655
20220023236
2022-01-27

Compositions and kits useful for treatment of respiratory illness

 #656
20220023200
2022-01-27

FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USES THEREOF

 #657
20220016312
2022-01-20

METHODS AND COMPOSITIONS TO GRAFT BONE USING IRON EXCIPIENTS

 #658
20220016109
2022-01-20

ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE

 #659
20220016044
2022-01-20

Oral Thin Films

 #660
20220015738
2022-01-20

COMBINED SUB-ILIOPSOAS AND SUBPECTINEAL BLOCKS-FOR HIP SURGERY

 #661
20220008703
2022-01-13

TRANSDERMAL DELIVERY OF HIGH VISCOSITY BIOACTIVE AGENTS

 #662
20220008412
2022-01-13

Ketamine or dextromethorphan formulations and methods of use

 #663
20220008363
2022-01-13

Bupropion as a modulator of drug activity

 #664
20220000863
2022-01-06

Pyrazine-containing compound

 #665
20220000809
2022-01-06

Combination treatments for opioid crisis

 #666
20220000799
2022-01-06

SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF

 #667
20210401831
2021-12-30

Bupropion as a modulator of drug activity

 #668
20210401830
2021-12-30

Bupropion as a modulator of drug activity

 #669
20210401829
2021-12-30

Bupropion as a modulator of drug activity

 #670
20210401828
2021-12-30

Bupropion as a modulator of drug activity

 #671
20210401827
2021-12-30

METHODS, PARENTERAL PHARMACEUTICAL FORMULATIONS, AND DEVICES FOR THE PREVENTION OF OPIOID OVERDOSE

 #672
20210401826
2021-12-30

ABUSE DETERRENT PHARMACEUTICAL FORMULATIONS

 #673
20210401825
2021-12-30

Pharmaceutical composition for nasal delivery

 #674
20210401824
2021-12-30

Parenteral Formulations of Dopamine Agonists

 #675
20210401751
2021-12-30

Compositions for treating viral infections and methods for same

 #676
20210393618
2021-12-23

BUPRENORPHINE TO TREAT RESPIRATORY DEPRESSION

 #677
20210393572
2021-12-23

PHARMACEUTICALLY ACTIVE CANNABIS-BASED COMPOSITIONS AND METHODS OF USE FOR TREATING GASTROINTESTINAL CONDITIONS

 #678
20210393513
2021-12-23

Methods of preparing a monodisperse oligo(ethylene glycol) reagent composition

 #679
20210386753
2021-12-16

METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM PRE-OPERATIVELY AND IN COMBINATION WITH OTHER DRUGS

 #680
20210379054
2021-12-09

Combination of dextromethorphan and bupropion for treating depression

 #681
20210378989
2021-12-09

ESKETAMINE FOR USE IN TREATING MAJOR DEPRESSIVE DISORDER

 #682
20210369703
2021-12-02

METHOD AND DEVICE OF TREATING CHRONIC KIDNEY DISEASE-ASSOCIATED PRURITUS

 #683
20210369628
2021-12-02

Injectable formulations of anesthetics for any pathological pain

 #684
20210361770
2021-11-25

Intranasal epinephrine formulations and methods for the treatment of disease

 #685
20210361645
2021-11-25

Bupropion as a modulator of drug activity

 #686
20210361576
2021-11-25

Liposome loading

 #687
20210356420
2021-11-18

ENZYME IMMOBILIZED ADHESIVE LAYER FOR ANALYTE SENSORS

 #688
20210355207
2021-11-18

Methods and kits for diagnosing and/or treating peripheral neuropathy

 #689
20210353562
2021-11-18

Compositions And Methods Useful For Treatment Of Respiratory Illness

 #690
20210353533
2021-11-18

Liquid naloxone spray

 #691
20210353504
2021-11-18

Mobile medical drug management systems and methods

 #692
20210348208
2021-11-11

Morphinan compounds

 #693
20210346505
2021-11-11

Oral formulations of kappa opioid receptor agonists

 #694
20210346469
2021-11-11

Compositions and Methods for Increasing Insulin Sensitivity

 #695
20210346373
2021-11-11

Dopamine D3 receptor selective antagonists/partial agonists and uses thereof

 #696
20210346370
2021-11-11

Bupropion as a modulator of drug activity

 #697
20210346311
2021-11-11

Base Composition for Tape Agent

 #698
20210338660
2021-11-04

Naloxegol oxalate and solid dispersion thereof

 #699
20210338605
2021-11-04

Bupropion as a modulator of drug activity

 #700
20210338574
2021-11-04

Intranasal pharmaceutical dosage forms comprising naloxone

 #701
20210330903
2021-10-28

Multiple Dose Nasal Spray of Naloxone

 #702
20210330884
2021-10-28

Emergency management implantable drug delivery systems

 #703
20210330794
2021-10-28

External preparation comprising non-lamellar liquid crystal-forming lipid

 #704
20210330667
2021-10-28

TOPICAL COMPOSITION OF NALBUPHINE AND METHOD FOR TREATING PRURITUS CONDITION, PAIN, OR INFLAMMATORY CONDITION BY USING THE SAME

 #705
20210322403
2021-10-21

SUBLINGUAL APOMORPHINE

 #706
20210322402
2021-10-21

Compositions for treating CMT and related disorders

 #707
20210315885
2021-10-14

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ZELLWEGER SPECTRUM DISORDER

 #708
20210315841
2021-10-14

CYCLOBENZAPRINE TREATMENT FOR SEXUAL DYSFUNCTION

 #709
20210308380
2021-10-07

Injector

 #710
20210308125
2021-10-07

Priming of cancer cells with low dose naltrexone

 #711
20210308124
2021-10-07

COMPOSITIONS FOR OPIATE AND OPIOID PREVENTION AND REVERSAL, AND METHODS OF THEIR USE

 #712
20210308073
2021-10-07

COMPOSITIONS COMPRISING PROPOFOL, KETAMINE, AND ANALGESIC, AND METHODS OF USE

 #713
20210308041
2021-10-07

Injectable buprenorphine formulation

 #714
20210299185
2021-09-30

MAPC TREATMENT OF BRAIN INJURIES AND DISEASES

 #715
20210299139
2021-09-30

Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids

 #716
20210299119
2021-09-30

Methods Of Providing Weight Loss Therapy In Patients With Major Depression

 #717
20210290857
2021-09-23

EMERGENCY DEVICES

 #718
20210290723
2021-09-23

Oligosaccharide formulations of kappa opioid receptor agonists

 #719
20210290592
2021-09-23

COMPOSITION AND METHOD FOR OPIOID SPARING

 #720
20210283126
2021-09-16

Methods For Reducing Binge Or Compulsive Eating

 #721
20210275520
2021-09-09

TRANSMUCOSAL DELIVERY DEVICE WITH ENHANCED UPTAKE

 #722
20210275519
2021-09-09

NASAL DRUG PRODUCTS AND METHODS OF THEIR USE

 #723
20210275444
2021-09-09

METHODS, PARENTERAL PHARMACEUTICAL FORMULATIONS, AND DEVICES FOR THE PREVENTION OF OPIOID OVERDOSE

 #724
20210268066
2021-09-02

METHODS AND KITS FOR TREATING PAIN

 #725
20210267968
2021-09-02

Compositions And Methods For Reducing Food Cravings

 #726
20210267967
2021-09-02

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

 #727
20210260054
2021-08-26

Bupropion as a modulator of drug activity

 #728
20210260053
2021-08-26

Early treatment of CMT disease

 #729
20210259975
2021-08-26

Formulations comprising hydralazine, prazosin, torsemide, spironolactone, and/or naltrexone and treatments using same

 #730
20210251983
2021-08-19

METHODS OF TREATMENT WITH BUPRENORPHINE

 #731
20210251907
2021-08-19

Encased tamper resistant controlled release dosage forms

 #732
20210246164
2021-08-12

PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF

 #733
20210244818
2021-08-12

Naltrexone Long Acting Formulations and Methods of Use

 #734
20210244742
2021-08-12

COMPOSITION COMPRISING A THERAPEUTIC AGENT AND A RESPIRATORY STIMULANT AND METHODS FOR THE USE THEREOF

 #735
20210244655
2021-08-12

SUBLINGUAL AND BUCCAL FILM COMPOSITIONS

 #736
20210230283
2021-07-29

Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies

 #737
20210228594
2021-07-29

METHODS FOR TREATING CARDIAC VALVE DISEASE

 #738
20210228571
2021-07-29

Methods and compositions for treating cancer

 #739
20210228570
2021-07-29

COMPOSITIONS AND METHODS FOR OPIOID OVERDOSE RESCUE

 #740
20210228543
2021-07-29

USE OF AMISULPRIDE AS AN ANTI-EMETIC

 #741
20210227865
2021-07-29

LOW GLYCEMIC COMPOSITION AND METHODS OF MAKING AND USING THEREOF

 #742
20210220348
2021-07-22

Bupropion as a modulator of drug activity

 #743
20210220347
2021-07-22

METHODS OF SAFELY TRANSITIONING A SUBJECT TO BUPRENORPHINE

 #744
20210220346
2021-07-22

FORMULATIONS AND METHODS FOR THE PREVENTION OF OPIOID OVERDOSE

 #745
20210220294
2021-07-22

Bupropion as a modulator of drug activity

 #746
20210220293
2021-07-22

Bupropion as a modulator of drug activity

 #747
20210220272
2021-07-22

BIPHASIX CANNABINOID DELIVERY

 #748
20210212952
2021-07-15

METHOD AND ENCAPSULATED SUBSTANCE FOR TREATING PAIN DUE TO A VARIETY OF DISEASES

 #749
20210212935
2021-07-15

Medical implant

 #750
20210205472
2021-07-08

Nanoparticle conjugated synthetic opioid prodrugs and methods of their uses

 #751
20210205297
2021-07-08

Bupropion as a modulator of drug activity

 #752
20210205296
2021-07-08

Treatments and prevention of opioid neonatal abstinence syndrome

 #753
20210205295
2021-07-08

Pharmaceutical dosage forms

 #754
20210205286
2021-07-08

Methods and compositions for treating autophagy related disease states and conditions utilizing AMPK activation

 #755
20210205240
2021-07-08

Bupropion as a modulator of drug activity

 #756
20210205239
2021-07-08

Bupropion as a modulator of drug activity

 #757
20210198268
2021-07-01

Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone

 #758
20210196706
2021-07-01

Systems and Methods for Treating an Opioid-Induced Adverse Pharmacodynamic Response

 #759
20210196705
2021-07-01

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

 #760
20210196704
2021-07-01

DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION

 #761
20210196703
2021-07-01

COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONISTS

 #762
20210196625
2021-07-01

Liquid naloxone spray

 #763
20210186957
2021-06-24

Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same

 #764
20210186956
2021-06-24

Method of decreasing the fluctuation index of dextromethorphan

 #765
20210186955
2021-06-24

Bupropion as a modulator of drug activity

 #766
20210186954
2021-06-24

DRUG PRODUCTS FOR NASAL ADMINISTRATION AND USES THEREOF

 #767
20210186923
2021-06-24

THERAPEUTIC FORMULATIONS AND USES THEREOF

 #768
20210186901
2021-06-24

Bupropion as a modulator of drug activity

 #769
20210186900
2021-06-24

Bupropion as a modulator of drug activity

 #770
20210186899
2021-06-24

Bupropion as a modulator of drug activity

 #771
20210177834
2021-06-17

DOSAGE FORMS AND METHODS FOR ENANTIOMERICALLY ENRICHED OR PURE BUPROPION

 #772
20210177833
2021-06-17

Opioid formulations

 #773
20210177779
2021-06-17

COMBINATIONS OF OPIOIDS AND N-ACYLETHANOLAMINES

 #774
20210169859
2021-06-10

Treatment and management of augmentation in restless legs syndrome

 #775
20210169810
2021-06-10

TAMPER RESISTANT DOSAGE FORMS

 #776
20210162055
2021-06-03

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

 #777
20210162051
2021-06-03

AQUEOUS-BASED COMPOSITIONS

 #778
20210161984
2021-06-03

Vaporized medicants and methods of use

 #779
20210161884
2021-06-03

Combination dosage form of a mu opioid receptor antagonist and an opioid agent

 #780
20210161835
2021-06-03

Combination treatments for opioid crisis

 #781
20210161465
2021-06-03

KIT FOR OPIOID OVERDOSE MONITORING

 #782
20210154301
2021-05-27

BIODEGRADABLE DRUG DELIVERY COMPOSITIONS

 #783
20210154154
2021-05-27

PREVENTING CRYSTALLIZATION OF ACTIVE INGREDIENTS IN TRANSDERMAL DELIVERY SYSTEMS

 #784
20210145829
2021-05-20

Organic compounds

 #785
20210145825
2021-05-20

USE OF OPIOID ANTAGONISTS

 #786
20210145789
2021-05-20

Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders

 #787
20210145753
2021-05-20

PREPARATION CONTAINING 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVES

 #788
20210145730
2021-05-20

PROCESS FOR PREPARING AN ORAL DISINTEGRATING DOSAGE FORM

 #789
20210145036
2021-05-20

LIPOPHILIC ACTIVE AGENT INFUSED COMPOSITIONS WITH REDUCED FOOD EFFECT

 #790
20210137916
2021-05-13

Opioid formulations

 #791
20210130071
2021-05-06

Packaging system for oxygen-sensitive drugs

 #792
20210128895
2021-05-06

DEVICE

 #793
20210128724
2021-05-06

CGRP ANTAGONISTS AND CLOSTRIDIAL DERIVATIVES FOR THE TREATMENT OF CORTICAL SPREADING DEPRESSION ASSOCIATED DISORDERS

 #794
20210128549
2021-05-06

OXYCODONE AND METHYLNALTREXONE MULTIPARTICULATES AND SUSPENSIONS CONTAINING THEM

 #795
20210128473
2021-05-06

LIPID DEPOT FORMULATIONS

 #796
20210128462
2021-05-06

Dry powder compositions for intranasal delivery

 #797
20210128078
2021-05-06

Opioid overdose monitoring

 #798
20210121493
2021-04-29

METHODS FOR TREATING LIVER DISEASES

 #799
20210121456
2021-04-29

USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION

 #800
20210121455
2021-04-29

Opioid receptor antagonist conjugate and use thereof

 #801
20210113542
2021-04-22

Methods and compositions for self-regulated release of active pharmaceutical ingredients

 #802
20210106546
2021-04-15

Bupropion as a modulator of drug activity

 #803
20210106542
2021-04-15

COMPOSITION AND METHOD FOR INHIBITING PLATELET AGGREGATION

 #804
20210094963
2021-04-01

Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone

 #805
20210093723
2021-04-01

Liquid compositions

 #806
20210093630
2021-04-01

GLUTAMATE AGENTS IN THE TREATMENT OF MENTAL DISORDERS

 #807
20210093629
2021-04-01

GLUTAMATE AGENTS IN THE TREATMENT OF MENTAL DISORDERS

 #808
20210093557
2021-04-01

NASAL DRUG PRODUCTS AND METHODS OF THEIR USE

 #809
20210085673
2021-03-25

DIHYDROETORPHINE FOR THE PROVISION OF PAIN RELIEF AND ANAESTHESIA

 #810
20210085672
2021-03-25

ORAL TABLET FORMULATIONS

 #811
20210085622
2021-03-25

Transmucosal film composition and methods of making and using the same

 #812
20210085617
2021-03-25

Immediate release abuse-deterrent granulated dosage forms

 #813
20210085602
2021-03-25

Injectable pharmaceutical formulation

 #814
20210085596
2021-03-25

COMPOSITIONS FOR ORAL MUCOADHESIVE DOSAGE FORMS

 #815
20210077484
2021-03-18

ABUSE DETERRENT COMPOSITIONS AND METHODS OF MAKING SAME

 #816
20210077483
2021-03-18

Bupropion as a modulator of drug activity

 #817
20210077429
2021-03-18

Bupropion as a modulator of drug activity

 #818
20210077428
2021-03-18

Bupropion as a modulator of drug activity

 #819
20210077426
2021-03-18

Analgesic formulation for control of pain in dogs

 #820
20210077409
2021-03-18

Pharmaceutical dosage forms

 #821
20210077392
2021-03-18

Dry powder compositions for intranasal delivery

 #822
20210077390
2021-03-18

Dry powder compositions for intranasal delivery

 #823
20210077382
2021-03-18

COMPOSITIONS, DEVICES, AND METHODS FOR THE TREATMENT OF OPIOID-RECEPTOR-MEDIATED CONDITIONS

 #824
20210072259
2021-03-11

Methods and materials for assessing and treating obesity

 #825
20210069181
2021-03-11

Compositions and methods for reducing major adverse cardiovascular events

 #826
20210069180
2021-03-11

METHODS FOR TREATING CHRONIC FATIGUE SYNDROME AND MYALGIC ENCEPHALOMYELITIS

 #827
20210069179
2021-03-11

Treatment of demyelinating diseases

 #828
20210069178
2021-03-11

Method for inducing a sustained immune response

 #829
20210069128
2021-03-11

Bupropion as a modulator of drug activity

 #830
20210069125
2021-03-11

Bupropion as a modulator of drug activity

 #831
20210060317
2021-03-04

Opioid overdose rescue device

 #832
20210060009
2021-03-04

Methods of treating acute depression and/or acute anxiety

 #833
20210060005
2021-03-04

Bupropion as a modulator of drug activity

 #834
20210060004
2021-03-04

Bupropion as a modulator of drug activity

 #835
20210059943
2021-03-04

Systems and methods addressing multiple aspects to provide a comprehensive recovery program for addictions, chronic conditions and diseases

 #836
20210052602
2021-02-25

Compositions and methods for pain management

 #837
20210052574
2021-02-25

Autoimmune therapy

 #838
20210052539
2021-02-25

Amino acid derivatives containing a disulfanyl group in the form of an NEP and APN inhibitor for the prevention and treatment of trigeminal nerve pain

 #839
20210052521
2021-02-25

Bupropion as a modulator of drug activity

 #840
20210047391
2021-02-18

ANTI-CGRP COMPOSITIONS AND USE THEREOF

 #841
20210046067
2021-02-18

Bupropion as a modulator of drug activity

 #842
20210046066
2021-02-18

ACETATE SALT OF BUPRENORPHINE AND METHODS FOR PREPARING BUPRENORPHINE

 #843
20210046065
2021-02-18

Composition for treating mental illness

 #844
20210046009
2021-02-18

PROTECTING ORAL OVERDOSE WITH ABUSE DETERRENT IMMEDIATE RELEASE FORMULATIONS

 #845
20210046000
2021-02-18

IMPLANTABLE POLYMERIC DEVICE FOR SUSTAINED RELEASE OF BUPRENORPHINE

 #846
20210045998
2021-02-18

TRANSDERMAL AND/OR DERMAL DELIVERY OF LIPOPHILIC ACTIVE AGENTS

 #847
20210043293
2021-02-11

TECHNIQUES FOR PROVIDING INTERACTIVE CLINICAL DECISION SUPPORT FOR DRUG DOSAGE REDUCTION

 #848
20210040094
2021-02-11

Morphinan derivative

 #849
20210038734
2021-02-11

MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES

 #850
20210038724
2021-02-11

BIODEGRADABLE DRUG DELIVERY COMPOSITIONS

 #851
20210038597
2021-02-11

Pyrazine-containing compound

 #852
20210038594
2021-02-11

Methods for treating antipsychotic-induced weight gain

 #853
20210038532
2021-02-11

TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING A SILICONE ACRYLIC HYBRID POLYMER

 #854
20210038522
2021-02-11

Method and compositions for rendering opioids safe

 #855
20210038507
2021-02-11

Vaginal systemic drug delivery

 #856
20210030751
2021-02-04

Bupropion as a modulator of drug activity

 #857
20210030750
2021-02-04

Bupropion as a modulator of drug activity

 #858
20210030749
2021-02-04

Combination of dextromethorphan and bupropion for treating depression

 #859
20210030748
2021-02-04

Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

 #860
20210030747
2021-02-04

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

 #861
20210030746
2021-02-04

METHODS AND COMPOSITIONS FOR TREATING CANCER

 #862
20210030745
2021-02-04

Methods and compositions for treating vasomotor symptoms

 #863
20210030693
2021-02-04

Pharmaceutical active-containing film delivery device for oral transmucosal administration

 #864
20210024515
2021-01-28

8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

 #865
20210023076
2021-01-28

Bupropion as a modulator of drug activity

 #866
20210023075
2021-01-28

Bupropion as a modulator of drug activity

 #867
20210023074
2021-01-28

TREATMENT OF DEMYELINATING DISEASES

 #868
20210023073
2021-01-28

Dextromethorphan extended release pharmaceutical composition

 #869
20210023043
2021-01-28

Methods of Treating Hyperalgesia

 #870
20210015848
2021-01-21

COMPOSITIONS AND THEIR USE IN THE TREATMENT OF ENDOMETRIOSIS AND PAIN

 #871
20210015815
2021-01-21

Bupropion as a modulator of drug activity

 #872
20210015814
2021-01-21

Bupropion as a modulator of drug activity

 #873
20210015813
2021-01-21

TREATMENT OF DEMYELINATING DISEASES

 #874
20210015812
2021-01-21

Methods for treating antipsychotic-induced weight gain

 #875
20210015768
2021-01-21

Bupropion as a modulator of drug activity

 #876
20210015742
2021-01-21

Subcutaneous Biodegradable Naltrexone Implant And Accompanying Behavioral Program For Weight Loss In A Patient

 #877
20210008063
2021-01-14

OXYMORPHONE CONTROLLED RELEASE COMPOSITIONS

 #878
20210008062
2021-01-14

Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

 #879
20210008061
2021-01-14

Abuse-resistant pharmaceutical composition for the treatment of opioid dependence

 #880
20210008060
2021-01-14

PHARMACEUTICAL COMPOSITION FOR NASAL DELIVERY

 #881
20210008059
2021-01-14

Pharmaceutical composition for nasal delivery

 #882
20210008058
2021-01-14

ENHANCEMENT OF IMPAIRED MOTOR AND MENTAL FUNCTIONS, USING DEXTROMETHORPHAN AND OXIDASE ENZYME INHIBITOR

 #883
20210008000
2021-01-14

TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING A SILICONE ACRYLIC HYBRID POLYMER

 #884
20210007973
2021-01-14

IMPLANTABLE DEVICES FOR DRUG DELIVERY WITH REDUCED BURST RELEASE

 #885
20210002226
2021-01-07

LEVORPHANOL PRODRUGS AND PROCESSES FOR MAKING AND USING THEM

 #886
20210000820
2021-01-07

Bupropion as a modulator of drug activity

 #887
20210000819
2021-01-07

ABUSE RESISTANT TRANSMUCOSAL DRUG DELIVERY DEVICE

 #888
20210000818
2021-01-07

Methods for treating depressive symptoms

 #889
20210000817
2021-01-07

Tableted medicinal composition comprising nalfurafine

 #890
20210000768
2021-01-07

Bupropion as a modulator of drug activity

 #891
20210000765
2021-01-07

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

 #892
20210000764
2021-01-07

Bupropion as a modulator of drug activity

 #893
20210000763
2021-01-07

BUPROPION AS A MODULATOR OF DRUG ACTIVITY

 #894
20210000756
2021-01-07

TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING A SILICONE ACRYLIC HYBRID POLYMER

 #895
20210000755
2021-01-07

TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF BUPRENORPHINE COMPRISING A SILICONE ACRYLIC HYBRID POLYMER

 #896
20210000749
2021-01-07

Tamper resistant dosage forms

 #897
20210000748
2021-01-07

Tamper resistant dosage forms

 #898
20210000747
2021-01-07

Tamper resistant dosage forms

 #899
20210000740
2021-01-07

COMPOSITIONS FOR SMALL MOLECULE THERAPEUTIC AGENT COMPOUNDS

 #900
20200405664
2020-12-31

Bupropion as a modulator of drug activity